{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:13Z","timestamp":1740108433182,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00296-021-04984-3","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T05:02:59Z","timestamp":1630731779000},"page":"2215-2224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The synergistic role of TNFA\u2009\u2212\u2009308G\/A and IL10\u2009\u2212\u20091082A\/G polymorphisms in ankylosing spondylitis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0441-3043","authenticated-orcid":false,"given":"Mariana","family":"Ivanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-6537","authenticated-orcid":false,"given":"Irena","family":"Manolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-9650","authenticated-orcid":false,"given":"Rumen","family":"Stoilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-9081","authenticated-orcid":false,"given":"Spaska","family":"Stanilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"issue":"9570","key":"4984_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390. https:\/\/doi.org\/10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"issue":"1","key":"4984_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cei.12670","volume":"183","author":"H Jethwa","year":"2016","unstructured":"Jethwa H, Bowness P (2016) The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin Exp Immunol 183(1):30\u201336. https:\/\/doi.org\/10.1111\/cei.12670","journal-title":"Clin Exp Immunol"},{"key":"4984_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/art.40150","volume":"69","author":"RJ Cuthbert","year":"2017","unstructured":"Cuthbert RJ, Fragkakis EM, Dunsmuir R, Li Z, Coles M, Marzo-Ortega H, Giannoudis PV, Jones E, El-Sherbiny YM, McGonagle D (2017) Brief report: group 3 innate lymphoid cells in human enthesis. Arthr Rheumatol 69:1816\u20131822. https:\/\/doi.org\/10.1002\/art.40150","journal-title":"Arthr Rheumatol"},{"issue":"8","key":"4984_CR4","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00296-011-1995-7","volume":"32","author":"A Taylan","year":"2012","unstructured":"Taylan A, Sari I, Kozaci DL, Yuksel A, Bilge S, Yildiz Y, Sop G, Coker I, Gunay N, Akkoc N (2012) Evaluation of the T helper 17 axis in ankylosing spondylitis. Rheumatol Int 32(8):2511\u20132515. https:\/\/doi.org\/10.1007\/s00296-011-1995-7","journal-title":"Rheumatol Int"},{"key":"4984_CR5","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","volume":"9","author":"A Watad","year":"2018","unstructured":"Watad A, Bridgewood C, Russell T, Marzo-Ortega H, Cuthbert R, McGonagle D (2018) The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front Immunol 9:2668. https:\/\/doi.org\/10.3389\/fimmu.2018.02668","journal-title":"Front Immunol"},{"issue":"11","key":"4984_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Lin Z, Wei Q, Jiang Y, Gu J (2009) Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int 29(11):1343\u20131347. https:\/\/doi.org\/10.1007\/s00296-009-0883-x","journal-title":"Rheumatol Int"},{"issue":"4","key":"4984_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.semarthrit.2004.08.005","volume":"34","author":"JC Davis Jr","year":"2005","unstructured":"Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34(4):668\u2013677. https:\/\/doi.org\/10.1016\/j.semarthrit.2004.08.005","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4984_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbadis.2009.01.007","volume":"1792","author":"MM Elahi","year":"2009","unstructured":"Elahi MM, Asotra K, Matata BM, Mastana SS (2009) Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 1792(3):163\u2013172. https:\/\/doi.org\/10.1016\/j.bbadis.2009.01.007","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"4984_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","volume":"33","author":"J Gratacos","year":"1994","unstructured":"Gratacos J, Collado A, Filella X, Sanmarti R, Canete J, Llena J, Molina R, Ballesta A, Mu\u00f1oz-G\u00f3mez J (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33(10):927\u2013931. https:\/\/doi.org\/10.1093\/rheumatology\/33.10.927","journal-title":"Br J Rheumatol"},{"issue":"4","key":"4984_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38(4):499\u2013505. https:\/\/doi.org\/10.1002\/art.1780380407","journal-title":"Arthritis Rheum"},{"issue":"7","key":"4984_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/acr.23097","volume":"69","author":"F Maas","year":"2017","unstructured":"Maas F, Arends S, Brouwer E, Essers I, van der Veer E, Efde M, van Ooijen PMA, Wolf R, Veeger NJGM, Bootsma H, Wink FR, Spoorenberg A (2017) Reduction in spinal radiographic progression in ankylosing spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 69(7):1011\u20131019. https:\/\/doi.org\/10.1002\/acr.23097","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4984_CR12","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1093\/nar\/13.17.6361","volume":"13","author":"GE Nedwin","year":"1985","unstructured":"Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, Goeddel DV, Gray PW (1985) Human lymphotoxin and tumor necrosis factor gene: structure, homology and chromosomal localization. Nucleic Acids Res 13:6361\u20136373. https:\/\/doi.org\/10.1093\/nar\/13.17.6361","journal-title":"Nucleic Acids Res"},{"key":"4984_CR13","doi-asserted-by":"publisher","first-page":"I20","DOI":"10.1136\/ard.58.2008.i20","volume":"58","author":"CL Verweij","year":"1999","unstructured":"Verweij CL (1999) Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis. Ann Rheum Dis 58:I20\u2013I26. https:\/\/doi.org\/10.1136\/ard.58.2008.i20","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4984_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1186\/s40064-016-3197-y","volume":"5","author":"RR El-Tahan","year":"2016","unstructured":"El-Tahan RR, Ghoneim AM, El-Mashad N (2016) TNF-\u03b1 gene polymorphisms and expression. Springerplus 5(1):1508. https:\/\/doi.org\/10.1186\/s40064-016-3197-y","journal-title":"Springerplus"},{"issue":"11","key":"4984_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/rheumatology\/kep260","volume":"48","author":"YH Lee","year":"2009","unstructured":"Lee YH, Song GG (2009) Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology (Oxford) 48(11):1359\u20131362. https:\/\/doi.org\/10.1093\/rheumatology\/kep260","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"4984_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10067-010-1499-y","volume":"29","author":"B Li","year":"2010","unstructured":"Li B, Wang P, Li H (2010) The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin Rheumatol 29(9):983\u2013990. https:\/\/doi.org\/10.1007\/s10067-010-1499-y","journal-title":"Clin Rheumatol"},{"issue":"11","key":"4984_CR17","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3899\/jrheum.110130","volume":"38","author":"DA Poddubnyy","year":"2011","unstructured":"Poddubnyy DA, M\u00e4rker-Hermann E, Kaluza-Schilling W, Zeidler H, Braun J, Listing J, Sieper J, Rudwaleit M (2011) Relation of HLA-B27, tumor necrosis factor-\u03b1 promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis\u2014a comprehensive genotype-phenotype analysis from an observational cohort. J Rheumatol 38(11):2436\u20132441. https:\/\/doi.org\/10.3899\/jrheum.110130","journal-title":"J Rheumatol"},{"key":"4984_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.humimm.2006.07.009","volume":"67","author":"G Vargas-Alarc\u00f3n","year":"2006","unstructured":"Vargas-Alarc\u00f3n G, Casasola-Vargas J, Rodr\u00edguez-P\u00e9rez JM, Huerta-Sil G, P\u00e9rez Hern\u00e1ndez N, Londo\u00f1o J, Pacheco-Tena C, Cardiel MH, Granados J, Burgos-Vargas R (2006) Tumor necrosis factor-\u03b1 promoter polymorphisms in mexican patients with spondyloarthritis. Hum Immunol 67:826\u2013832. https:\/\/doi.org\/10.1016\/j.humimm.2006.07.009","journal-title":"Hum Immunol"},{"key":"4984_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/ard.2006.065888","volume":"66","author":"M-Y Shiau","year":"2007","unstructured":"Shiau M-Y, Lo M-K, Chang C-P, Yang T-P, Ho K-T, Chang Y-H (2007) Association of tumour necrosis factor \u03b1 promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis 66:562\u2013563. https:\/\/doi.org\/10.1136\/ard.2006.065888","journal-title":"Ann Rheum Dis"},{"key":"4984_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765. https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.683","journal-title":"Annu Rev Immunol"},{"key":"4984_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva M, O\u2019Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170\u2013181. https:\/\/doi.org\/10.1038\/nri2711","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"4984_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"MR de Waal","year":"1991","unstructured":"de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174(5):1209\u20131220. https:\/\/doi.org\/10.1084\/jem.174.5.1209","journal-title":"J Exp Med"},{"key":"4984_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/critrevimmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32:23\u201363. https:\/\/doi.org\/10.1615\/critrevimmunol.v32.i1.30","journal-title":"Crit Rev Immunol"},{"issue":"7","key":"4984_CR24","doi-asserted-by":"publisher","first-page":"e69547","DOI":"10.1371\/journal.pone.0069547.t003","volume":"8","author":"P Liu","year":"2013","unstructured":"Liu P, Song J, Su H, Li L, Lu N, Yang R, Peng Z (2013) IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS ONE 8(7):e69547. https:\/\/doi.org\/10.1371\/journal.pone.0069547.t003","journal-title":"PLoS ONE"},{"key":"4984_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"SM Van der Linden","year":"1984","unstructured":"Van der Linden SM, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4984_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/gtmb.2017.0169","volume":"22","author":"I Manolova","year":"2018","unstructured":"Manolova I, Miteva L, Ivanova M, Kundurzhiev T, Stoilov R, Stanilova S (2018) The synergistic effect of TNFA and IL10 promoter polymorphisms on genetic predisposition to systemic Lupus Erythematosus. Genet Test Mol Biomark 22(2):135\u2013140. https:\/\/doi.org\/10.1089\/gtmb.2017.0169","journal-title":"Genet Test Mol Biomark"},{"issue":"6","key":"4984_CR27","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/13102818.2014.972147","volume":"28","author":"I Manolova","year":"2014","unstructured":"Manolova I, Ivanova M, Stoilov R, Rashkov R, Stanilova S (2014) Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis. Biotechnol Equip 28(6):1108\u20131114. https:\/\/doi.org\/10.1080\/13102818.2014.972147","journal-title":"Biotechnol Equip"},{"key":"4984_CR28","doi-asserted-by":"publisher","unstructured":"Hohler T, Schaper T, Schneider PM, Meyer ZBK, Marker-Hermann E (1998) Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 41:1489\u22121492. https:\/\/doi.org\/10.1002\/1529-0131(199808)41:8<1489::AID-ART20>3.0.CO;2-5","DOI":"10.1002\/1529-0131(199808)41:8<1489::AID-ART20>3.0.CO;2-5"},{"key":"4984_CR29","first-page":"1110","volume":"26","author":"F McGarry","year":"1999","unstructured":"McGarry F, Walker R, Sturrock R, Field M (1999) The \u2212308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 26:1110\u20131116","journal-title":"J Rheumatol"},{"issue":"8","key":"4984_CR30","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3899\/jrheum.131315","volume":"41","author":"JC Nossent","year":"2014","unstructured":"Nossent JC, Sagen-Johnsen S, Bakland G (2014) Tumor necrosis factor-\u03b1 promoter -308\/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-\u03b1 and does not predict TNF inhibitor response. J Rheumatol 41(8):1675\u20131682. https:\/\/doi.org\/10.3899\/jrheum.131315","journal-title":"J Rheumatol"},{"key":"4984_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/ard.60.1.36","volume":"60","author":"M Rudwaleit","year":"2001","unstructured":"Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A, Sieper J, Braun J (2001) Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF\u2013308 gene polymorphism. Ann Rheum Dis 60:36\u201342. https:\/\/doi.org\/10.1136\/ard.60.1.36","journal-title":"Ann Rheum Dis"},{"key":"4984_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10067-006-0283-5","volume":"26","author":"A Bal","year":"2007","unstructured":"Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R (2007) Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26:211\u2013215. https:\/\/doi.org\/10.1007\/s10067-006-0283-5","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4984_CR33","doi-asserted-by":"publisher","first-page":"E370","DOI":"10.25011\/cim.v34i6.15898","volume":"34","author":"C Lv","year":"2011","unstructured":"Lv C, Wang Y, Wang J, Zhang H, Xu H, Zhang D (2011) Association of Interleukin-10 gene polymorphisms with ankylosing spondylitis. Clin Invest Med 34(6):E370. https:\/\/doi.org\/10.25011\/cim.v34i6.15898","journal-title":"Clin Invest Med"},{"key":"4984_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653611","volume":"12","author":"M Braga","year":"2021","unstructured":"Braga M, Lara-Armi FF, Neves JSF, Rocha-Loures MA, Terron-Monich MS, Bahls-Pinto LD, Lima Neto QA, Zacarias JMV, Sell AM, Visentainer JEL (2021) Influence of IL10 (rs1800896) polymorphism and TNF-a, IL-10, IL-17A, and IL-17F serum levels in ankylosing spondylitis. Front Immunol 12:653611. https:\/\/doi.org\/10.3389\/fimmu.2021.653611","journal-title":"Front Immunol"},{"issue":"4","key":"4984_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/jmg.40.4.296","volume":"40","author":"D Lio","year":"2003","unstructured":"Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonaf\u00e9 M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C (2003) Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 40(4):296\u2013299. https:\/\/doi.org\/10.1136\/jmg.40.4.296","journal-title":"J Med Genet"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04984-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04984-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04984-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T10:24:49Z","timestamp":1635243889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04984-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4984"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04984-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Mariana Ivanova declares that she has no conflict of interest. Author Irena Manolova declares that she has no conflict of interest. Author Rumen Stoilov declares that he has no conflict of interest. Author Spaska Stanilova declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}